Fenbendazole oral suspension
5%, 10%
- Packaging500 ml/1 L
- MOQ500 L
- Shelf life24 months
Triclabendazole and Levamisole oral suspension
Oral suspension manufactured on the oral-solution line. Homogeneity through the shelf life is validated batch by batch, since sedimentation is the usual failure mode for this dosage form. Private-label bottling available.
| Strengths | 7.5%+12% |
|---|---|
| Species | Poultry, swine |
| Route | Oral |
| Standard pack | 500 ml/1 L |
| Minimum order | 500 L |
| Shelf life | 24 months from date of manufacture |
| Storage | Below 25 °C, dry |
| Manufacturing | Own GMP line, veterinary GMP No. (2022) 04028; batch COA with every shipment |
| Registration | Dossier support available for market-specific submission |
Packaging & private label
Packed the way your market expects it.
- HDPE bottle with graduated dosing support
- Shake-before-use and batch details printed per destination-market label
- Private-label bottling available
Regulatory note. Product names identify manufacturing capability, not a marketing authorisation. Registration status, approved strengths and label wording are decided by the competent authority in your destination country. We supply licensed distributors and registration holders only.
Related
Manufactured on the same line.
Albendazole oral suspension
2.5%/5%/10%
- Packaging500 ml/1 L
- MOQ500 L
- Shelf life24 months
Albendazole and ivermection oral suspension
2.5%+0.1%, 3.5%+0.1%
- Packaging500 ml/1 L
- MOQ500 L
- Shelf life24 months